GemPharmatech (SH:688046) Xin Lang Cai Jing·2025-11-03 02:38Core Viewpoint - The stock of Yaokang Bio has increased by 5.05%, reaching a price of 18.72 CNY per share, with a total market capitalization of 7.675 billion CNY as of the report date [1]. Company Overview - Jiangsu Jicui Yaokang Biotechnology Co., Ltd. was established on December 29, 2017, and went public on April 25, 2022. The company is located in Nanjing, Jiangsu Province [1]. - The main business involves the research, production, and sales of laboratory animal mouse models, along with related technical services [1]. Revenue Composition - The revenue breakdown of the main business is as follows: - Commercial mouse model sales: 55.36% - Functional efficacy: 23.46% - Custom breeding: 11.32% - Model creation: 7.06% - Import and export agency and others: 2.70% - Other (supplementary): 0.09% [1]. Shareholder Information - Noan Fund's Noan Pioneer Mixed A (320003) is among the top ten circulating shareholders of Yaokang Bio. In the third quarter, it reduced its holdings by 265,200 shares, now holding 5.0687 million shares, which is 1.24% of the circulating shares [2]. - The fund has achieved a year-to-date return of 37.47%, ranking 2135 out of 8223 in its category, and a one-year return of 40.92%, ranking 1586 out of 8115 [2]. Fund Manager Profile - The fund manager of Noan Pioneer Mixed A is Yang Gu, who has a cumulative tenure of 19 years and 260 days. The fund's total asset size is 5.837 billion CNY, with the best return during his tenure being 1099.07% and the worst being 8.34% [3].